[ Price : $8.95]
UCB says it is ending the development of minzasolmin, a drug it was working on with Novartis to treat early Parkinsons disease, af...[ Price : $8.95]
FDA issues an alert against the use of certain Baxter Solution Sets with Duo-Vent Spikes because they were incorrectly assembled w...[ Price : $8.95]
FDA issues a complete response letter for Zealands glepaglutide intended to treat short bowel syndrome.[ Price : $8.95]
FDA warns a Viatris Mylan drug manufacturing facility in Pradesh, India, about CGMP violations involving quality and data issues.[ Price : $8.95]
FDA adds a liver injury Boxed Warning to labeling for Astellas menopause hot flash drug Veozah.[ Price : $8.95]
FDA warns Albuquerque, NM-based Sombra Cosmetics about CGMP violations in the manufacturing of finished drugs.[ Price : $8.95]
FDA approves Mesoblasts Ryoncil to treat some graft-versus-host disease pediatric patients.[ Price : $8.95]
FDA publishes an International Council for Harmonization draft M15 guidance on model-informed drug development principles.